NCT00339183 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 591
- group Id
- BG001
- value
- 595
- group Id
- BG002
- value
- 1186
- units
- Participants
- groups
- description
- Participants were randomized to 6 mg/kg panitumumab intravenous infusion plus a standard chemotherapy regimen (FOLFIRI) consisting of 5-FU, leucovorin and irinotecan. Treatment was administered in cycles every two weeks.
- id
- BG000
- title
- Panitumumab Plus FOLFIRI
- description
- Participants were randomized to receive a standard chemotherapy regimen (FOLFIRI) consisting of 5-FU, leucovorin and irinotecan. Treatment was administered in cycles every two weeks.
- id
- BG001
- title
- FOLFIRI Alone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.5
- value
- 60.2
- group Id
- BG001
- spread
- 10.6
- value
- 60.9
- group Id
- BG002
- spread
- 10.5
- value
- 60.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 245
- group Id
- BG001
- value
- 219
- group Id
- BG002
- value
- 464
- title
- Female
- measurements
- group Id
- BG000
- value
- 346
- group Id
- BG001
- value
- 376
- group Id
- BG002
- value
- 722
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 568
- group Id
- BG001
- value
- 569
- group Id
- BG002
- value
- 1137
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 9
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 20
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Aborigine
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 303
- group Id
- BG001
- value
- 294
- group Id
- BG002
- value
- 597
- title
- Wild-type KRAS
- categories
- measurements
- group Id
- BG000
- value
- 238
- group Id
- BG001
- value
- 248
- group Id
- BG002
- value
- 486
- title
- Mutant KRAS
- categories
- measurements
- group Id
- BG000
- value
- 50
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 103
- title
- Unevaluable KRAS
- description
- KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene
- param Type
- NUMBER
- title
- KRAS Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 182
- group Id
- BG002
- value
- 361
- title
- No
- categories
- measurements
- group Id
- BG000
- value
- 412
- group Id
- BG001
- value
- 413
- group Id
- BG002
- value
- 825
- title
- Yes
- description
- mCRC: metastatic colorectal cancer
- param Type
- NUMBER
- title
- Prior Oxaliplatin Exposure for mCRC
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 480
- group Id
- BG001
- value
- 483
- group Id
- BG002
- value
- 963
- title
- No
- categories
- measurements
- group Id
- BG000
- value
- 111
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 223
- title
- Yes
- param Type
- NUMBER
- title
- Prior Bevacizumab Exposure for mCRC
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 564
- group Id
- BG001
- value
- 565
- group Id
- BG002
- value
- 1129
- title
- Grade 0 or 1
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 57
- title
- Grade 2
- description
- Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about \> 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair \> 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 591
- group Id
- BG001
- value
- 595
- group Id
- BG002
- value
- 1186
- units
- Participants
- groups
- description
- Participants were randomized to 6 mg/kg panitumumab intravenous infusion plus a standard chemotherapy regimen (FOLFIRI) consisting of 5-FU, leucovorin and irinotecan. Treatment was administered in cycles every two weeks.
- id
- BG000
- title
- Panitumumab Plus FOLFIRI
- description
- Participants were randomized to receive a standard chemotherapy regimen (FOLFIRI) consisting of 5-FU, leucovorin and irinotecan. Treatment was administered in cycles every two weeks.
- id
- BG001
- title
- FOLFIRI Alone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.5
- value
- 60.2
- group Id
- BG001
- spread
- 10.6
- value
- 60.9
- group Id
- BG002
- spread
- 10.5
- value
- 60.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 245
- group Id
- BG001
- value
- 219
- group Id
- BG002
- value
- 464
- title
- Female
- measurements
- group Id
- BG000
- value
- 346
- group Id
- BG001
- value
- 376
- group Id
- BG002
- value
- 722
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 568
- group Id
- BG001
- value
- 569
- group Id
- BG002
- value
- 1137
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 9
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 20
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Aborigine
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 303
- group Id
- BG001
- value
- 294
- group Id
- BG002
- value
- 597
- title
- Wild-type KRAS
- categories
- measurements
- group Id
- BG000
- value
- 238
- group Id
- BG001
- value
- 248
- group Id
- BG002
- value
- 486
- title
- Mutant KRAS
- categories
- measurements
- group Id
- BG000
- value
- 50
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 103
- title
- Unevaluable KRAS
- description
- KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene
- param Type
- NUMBER
- title
- KRAS Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 182
- group Id
- BG002
- value
- 361
- title
- No
- categories
- measurements
- group Id
- BG000
- value
- 412
- group Id
- BG001
- value
- 413
- group Id
- BG002
- value
- 825
- title
- Yes
- description
- mCRC: metastatic colorectal cancer
- param Type
- NUMBER
- title
- Prior Oxaliplatin Exposure for mCRC
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 480
- group Id
- BG001
- value
- 483
- group Id
- BG002
- value
- 963
- title
- No
- categories
- measurements
- group Id
- BG000
- value
- 111
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 223
- title
- Yes
- param Type
- NUMBER
- title
- Prior Bevacizumab Exposure for mCRC
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 564
- group Id
- BG001
- value
- 565
- group Id
- BG002
- value
- 1129
- title
- Grade 0 or 1
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 57
- title
- Grade 2
- description
- Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about \> 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair \> 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle